Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674275 | SCV000799584 | likely pathogenic | DE SANCTIS-CACCHIONE SYNDROME; Cerebrooculofacioskeletal syndrome 1; Cockayne syndrome type 2 | 2018-04-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001386142 | SCV001586274 | pathogenic | not provided | 2023-09-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys1198Argfs*4) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with Cockayne syndrome (PMID: 19894250). For these reasons, this variant has been classified as Pathogenic. |